alexa Does Fibromyalgia Sit in a Chair? Symptomatic Relief wi

Fibromyalgia: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Does Fibromyalgia Sit in a Chair? Symptomatic Relief with a Simulated Jogging Device

Sackner MA1* and Adams JA2

1Sackner Wellness Products LLC, Miami FL 33137, USA

2Mt Sinai Medical Center Div Neonatology, Mt Sinai Medical Center, USA

*Corresponding Author:
Sackner MA
Sackner Wellness Products LLC
555 NE 34th Street, PH1, Miami FL 33137, USA
Tel: 305-333-881
E-mail: [email protected]

Received date: March 28, 2017; Accepted date: April 28, 2017; Published date: May 06, 2017

Citation: Sackner MA, Adams JA (2017) Does Fibromyalgia Sit in a Chair? Symptomatic Relief with a Simulated Jogging Device. Fibrom Open Access 2:117.

Copyright: © 2017 Sackner MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

The symptoms of fibromyalgia are associated with physical inactivity such as excessive sitting. Physical inactivity itself produces increased oxidative stress and chronic inflammation, factors present in fibromyalgia. Therefore, increasing physical activity should benefit patients with fibromyalgia. Even in normal subjects, only about 10 to 20% of American adults comply with physical activity guidelines. We report effectiveness of daily use of a passive motion platform over a four-week period that releases endothelial nitric oxide as occurs during active exercise. The primary endpoint of this study was the Fibromyalgia Impact Questionnaire (FIQ). Improvement of FIQ with the motion platform was comparable to drug studies over the same time-period. Since the motion platform was not portable, patients needed to visit a fixed location within a hospital clinic to receive daily treatments and as time went by dropouts increased limiting its feasibility for longer-term studies. In this paper, we describe a portable, passive simulated jogging device that is low-cost and targeted to home use for future long-term evaluation as primary treatment or ancillary to drug therapies for fibromyalgia.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords